menu
    • menu

    Company profile for Haystack Oncology

    NEW Drugs in Dev: 2
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Haystack Oncology is built upon two decades of expertise in liquid biopsy technology and clinical development, spearheaded by scientists specializing in cancer genomics. These pioneers envisioned non-invasive cancer screening, minimal residual disease (MRD) detection, and advanced disease therapy monitoring. The impact of their discoveries has been transformative, positively influencing the lives of millions. Furthermore, comp...
    Haystack Oncology is built upon two decades of expertise in liquid biopsy technology and clinical development, spearheaded by scientists specializing in cancer genomics. These pioneers envisioned non-invasive cancer screening, minimal residual disease (MRD) detection, and advanced disease therapy monitoring. The impact of their discoveries has been transformative, positively influencing the lives of millions. Furthermore, companies leveraging their technology have collectively generated billions of dollars in enterprise value.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Haystack OncologyUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    301 West 29th Street, STE 2004U Baltimore, MD 21211
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://haystackoncology.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/haystack-oncology/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    RDD

    RDD

    Not Confirmed

    envelop Contact Supplier

    RDD

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    MVZ HPH Introduces Haystack Mrd®-Based Ctdna Cancer Monitoring
    MVZ HPH Introduces Haystack Mrd®-Based Ctdna Cancer Monitoring

    17 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/mvz-hph-brings-ctdna-blood-test-for-cancer-monitoring-to-europe-based-on-haystack-mrd-technology-from-quest-diagnostics-302586613.html

    PR NEWSWIRE
    17 Oct 2025
    Share Share
    Haystack, Rutgers Launch MRD Study In Post-Surgical Lung Cancer
    Haystack, Rutgers Launch MRD Study In Post-Surgical Lung Cancer

    22 Sep 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/haystack-oncology-and-rutgers-cancer-institute-collaborate-in-a-clinical-study-to-examine-haystack-mrd-as-a-guide-for-post-surgical-treatment-for-lung-cancer-302561905.html

    PR NEWSWIRE
    22 Sep 2025
    Share Share
    Haystack And Lisata Partner On Pancreatic Cancer Therapy Evaluation
    Haystack And Lisata Partner On Pancreatic Cancer Therapy Evaluation

    18 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/07/18/2915216/18623/en/Haystack-Oncology-and-Lisata-Therapeutics-Initiate-Research-Collaboration-to-Use-the-Haystack-MRD-Technology-to-Evaluate-Efficacy-of-Pancreatic-Cancer-Therapy.html

    GLOBENEWSWIRE
    18 Jul 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search